New Article Showing the Unique Mechanism of Action Behind Alzstatin as an Alzheimer's Treatment

February 24, 2025 4:50 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) ), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer's disease and pain, announced today that a scientific article has been published with novel preclinical data about Alzstatin, the biological effects that could be achieved by the treatment, and the interesting opportunities this brings in the continued development of the...

Read more

Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1

February 24, 2025 2:00 AM

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO) is pleased to announce the administration of its first-in-human dose of HG-CT-1, its proprietary CAR-T cell therapy, for the treatment of relapsed or refractory acute myeloid leukemia (R/R AML) in adults. This marks a major milestone in the Company's clinical development program, demonstrating progress toward delivering a potentially life-saving treatment for...

Read more

Clarification of Promotional Activities

February 21, 2025 7:35 PM

VANCOUVER, BC / ACCESS Newswire / February 21, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:4XT) reports a clarification to its news release dated January 31, 2025, at the request of the Canadian Investment Regulatory Organization ("CIRO").The Company engaged Apaton Finance GmbH ("Apaton"), wholly owned by Mario Hose, of Ellernstr. 34, 30175 Hannover, Germany (email: [email protected]; phone: +49...

Read more

Onco-Innovations Provides Information Regarding Inka Health's USPTO Provisional Patent Application for AI-Powered Precision Medicine Platform, SynoGraph

February 21, 2025 6:05 PM

Onco-Innovations Limited(CSE:ONCO)(OTCQB:ONNVF) (Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly owned subsidiary, Inka Health ("Inka"), filed a provisional patent application with the United States Patent and Trademark Office (USPTO) for its next-generation AI platform, SynoGraph. The patent application, titled, "Method and System for Causal Graph Generation and Analysis", was filed on January 28,...

Read more

Black Book Research Releases 2025 Rural Healthcare IT Solutions Report Addressing Interoperability Challenges & Technology Gaps

February 21, 2025 5:35 PM

Black Book Research, a leading independent research firm specializing in healthcare technology evaluations, has released its 2025 Black Book of Rural and Critical Access Healthcare IT Solutions. This report, accesible by simple registration, is based on survey responses from 972 rural healthcare executives, IT professionals, clinicians, and administrators, highlights critical technology trends, vendor performance, and persistent interoperability...

Read more

New Guidelines Released for Self-Collected HPV Screening

February 21, 2025 1:30 PM

Nine months after the U.S. Food and Drug Administration (FDA) approved self-collected Human Papillomavirus (HPV) testing as an alternative method of cervical cancer screening, the first-ever guidelines have been released to incorporate the option into clinical practice. The guidelines, "Self-collected vaginal specimens for HPV testing: Recommendations from the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee,"...

Read more

EndoUVtech Announces Manufacturing Agreement with a Leading Global Provider of Medical Technologies

February 21, 2025 12:50 PM

EndoUVtech, an innovative medical device company committed to improving outcomes for ischemic stroke patients and other cardiovascular conditions, today announced a manufacturing agreement with a leading global provider of medical technologies. Under the agreement, the global partner will leverage its extensive manufacturing capabilities to produce EndoUVtech's proprietary UV Balloon Catheter - an essential component of the company's Smart UV...

Read more

Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market

February 21, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or Telomir, a leader in age-reversal science, today announced a breakthrough achievement-Telomir-1 has successfully captured and stabilized both Silver(I) (Ag⁺) and the highly reactive Silver(II) (Ag²⁺) in a biologically compatible form. This milestone overcomes a major limitation in silver-based medical applications, opening the door for advanced antimicrobial treatments, wound care solutions, and...

Read more

Protagonist Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

February 21, 2025 7:00 AM

NEWARK, CA / ACCESS Newswire / February 21, 2025 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended December 31, 2024, and provided a corporate update."Protagonist is quickly approaching multiple late-stage transformational events expected in the first quarter of this year, including the topline results from the VERIFY Phase 3 study of rusfertide...

Read more

Cantargia Publishes Full Year Report for 2024

February 21, 2025 1:20 AM

Cantargia (STO:CANTA) Cantargia AB's (publ) ("Cantargia") (Nasdaq Stockholm:CANTA) full year report for 2024 is now available on the company's web page www.cantargia.com/en/investors/financial-reports."We now have two products in clinical development: CAN10 in immune and inflammatory diseases and nadunolimab in pancreatic cancer and other tumors. Both projects offer the possibility to transform the treatment and the lives of patients with...

Read more

Onco-Innovations Announces U.S. Listing on the OTCQB Market

February 21, 2025 12:10 AM

Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its common shares have commenced trading on the OTCQB marketplace under the symbol "ONNVF". The Company's shares will continue to trade on the Canadian Securities Exchange under the symbol "ONCO".The listing on the OTCQB is a step in enhancing the Company's visibility and accessibility for U.S. investors. This...

Read more

Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement

February 20, 2025 6:15 PM

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology (Nasdaq:ASBP)(Nasdaq:ASBPW), today announced that it entered into a definitive Securities Purchase Agreement (the "Agreement") on February 19, 2025, pursuant to which the Company issued to the Buyers a senior secured convertible debenture (the...

Read more

Dr. Ammar Mahmoud Featured in Exclusive Interview on Innovation and Compassion in Cosmetic Surgery

February 20, 2025 5:30 PM

Dr. Ammar Mahmoud, a highly regarded cosmetic gynecological surgeon, is redefining the way women experience cosmetic surgery and intimate wellness. In a newly released exclusive interview, Dr. Mahmoud shares his insights on customized treatment, the power of patient education, and the growing role of technology in women's health.Based in New York City, Dr. Mahmoud has built his career around helping women feel comfortable, confident, and...

Read more

Jolt Health Inc. Announces Share Consolidation

February 20, 2025 4:45 PM

VANCOUVER, BC / ACCESS Newswire / February 20, 2025 / Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT)(FSE:G1Q0) announces it intends to proceed with a consolidation of its common shares (each, a "Share") on the basis of twenty (20) pre-consolidation Shares for one (1) post-consolidation Share (the "Consolidation"). The shareholders approved the Consolidation at the Annual and Special Meeting held on December 30, 2024, and the Board of...

Read more

The Power of Family Involvement in Eating Disorder Recovery: How Loved Ones Can Make a Difference

February 20, 2025 4:15 PM

WEST PALM BEACH, FL / ACCESS Newswire / February 20, 2025 / ViaMar Health, a leading eating disorder treatment center, was recently featured in an exclusive online blog exploring the crucial role of family involvement in recovery. Titled "The Power of Family Involvement in Eating Disorder Recovery: How Loved Ones Can Make a Difference," the blog highlights how families can provide essential support, foster connection, and contribute to the...

Read more

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

February 20, 2025 4:05 PM

RANCHO CUCAMONGA, CA / ACCESS Newswire / February 20, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its Fourth quarter of 2024 ended December 31, 2024, after the market closes on Thursday, February 27, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.To access the conference call, dial toll free 877-407-0989, for international calls, dial...

Read more

Emergency Care Partners and Professional Emergency Medicine Management Expand Services to Rapides Regional Medical Center

February 20, 2025 2:10 PM

Emergency Care Partners (ECP) and its Louisiana-based partner physician group Professional Emergency Medicine Management (PEMM) announced an expansion to provide emergency medicine services at Rapides Regional Medical Center in Alexandria, Louisiana. PEMM's affiliated partner, Inhospital Physicians (IHP), will provide hospitalist and intensivist services. All three programs began on Feb. 7, 2025.Rapides Regional Medical Center, part of HCA...

Read more

Glidewell Launches Glidewell(TM) Tooth Replacement Solution for Implant Treatment

February 20, 2025 12:00 PM

Glidewell, a leading innovator of dental technology, has launched the Glidewell™ Tooth Replacement Solution, a comprehensive implant treatment bundle that digitally optimizes every stage of treatment. As a full-scale manufacturer of dental implants and the nation's largest dental lab, Glidewell offers the full range of implant solutions, from implants, to digital treatment planning and surgical guides, to prosthetic components and final...

Read more

TridentCare Joins Southwestern Health Resources Preferred Provider Network to Expand Portable Diagnostic Services to ACO Members Across North Texas

February 20, 2025 11:00 AM

TridentCare, the leading provider of portable diagnostic services in the country, and Southwestern Health Resources (SWHR), the clinically integrated network formed between UT Southwestern Medical Center (UTSW) and Texas Health Resources, announced today that TridentCare is a preferred network provider of Southwestern Health Resources. As a preferred network provider, TridentCare will bring access to portable diagnostic imaging services to more...

Read more

The Longevity Centers Introduces Stellate Ganglion Block (SGB) Injections for Nervous System Regulation

February 20, 2025 10:00 AM

Patients at The Longevity Center have another safe and effective option for reducing symptoms related to stress, anxiety, pain, and inflammation. Stellate Ganglion Block (SGB) injections, which are now available at The Longevity Center's integrative health clinic in West Palm Beach, Florida, are an innovative tool for helping address imbalances in the autonomic nervous system. By adding the injections to its treatment list, The Longevity Center...

Read more